In the case of ovarian cancer tumors, it has been reported that elevated levels of CD44- and CD133-positive cells were associated with chemotherapy-resistant patients and were present in metastatic and recurrent tumors (reviewed in [4]). This evidence concerns the gene PROM1 and ovarian carcinoma.